SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-077668
Filing Date
2015-11-10
Accepted
2015-11-10 16:31:28
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-18044_110q.htm 10-Q 972759
2 EX-10.1 a15-18044_1ex10d1.htm EX-10.1 434560
3 EX-31.1 a15-18044_1ex31d1.htm EX-31.1 13072
4 EX-31.2 a15-18044_1ex31d2.htm EX-31.2 12351
5 EX-32.1 a15-18044_1ex32d1.htm EX-32.1 7844
6 EX-32.2 a15-18044_1ex32d2.htm EX-32.2 7756
13 GRAPHIC g180441kk05i001.jpg GRAPHIC 29754
14 GRAPHIC g180441kk07i001.gif GRAPHIC 48084
  Complete submission text file 0001104659-15-077668.txt   4925304

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT loxo-20150930.xml EX-101.INS 1045749
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20150930.xsd EX-101.SCH 29554
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20150930_cal.xml EX-101.CAL 27007
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20150930_def.xml EX-101.DEF 110561
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20150930_lab.xml EX-101.LAB 309904
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20150930_pre.xml EX-101.PRE 212404
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 151219332
SIC: 2834 Pharmaceutical Preparations